Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2025-04 · 17 (2)
DOI: 10.1002/dad2.70132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 16.06.2025. Verfasst von Sunu Mathew und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroimaging Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis Indiana USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NLM NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Retinal vasculature could be a novel, non‐invasive, and inexpensive biomarker for Alzheimer's disease (AD) ‐related neuropathology. In this comprehensive review and meta‐analysis from studies that assessed retinal vasculature using optical coherence tomography angiography in AD dementia, we calculated the pooled standardized mean differences (SMDs) in vascular density (VD)‐whole, VD‐parafoveal, vessel length density (VLD) and foveal avascular zone (FAZ) between AD and cognitively normal (CN), and between mild cognitive impairment (MCI) and CN. Thirty‐six studies were included in the meta‐analysis. The pooled SMD between AD and CN in VD‐whole, VD‐parafoveal, VLD, and FAZ was ‐0.69 ( p < 0.01), ‐0.38 ( p = 0.01), ‐0.59 ( p < 0.01), and 0.33 ( p = 0.06), respectively, and between MCI and CN in VD‐whole, VD‐parafoveal, VLD, and FAZ was ‐0.36 ( p = 0.03), ‐0.17 ( p = 0.44), ‐0.34 ( p = 0.03), and 0.31 ( p = 0.07), respectively. We identified a significant reduction in retinal vasculature in AD and MCI compared to CN. Highlights We performed a meta‐analysis of 36 studies using optical coherence tomography angiography to assess the retinal vasculature. These included 4129 participants, of which 1175 had Alzheimer's disease (AD), 1004 had mild cognitive impairment, and 1926 were cognitively normal. We identified a significant reduction in retinal vasculature in AD and mild cognitive impairment compared to cognitively normal. Retinal perfusion measured using optical coherence tomography angiography could be used as a potential biomarker for AD dementia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Neuroimaging Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis Indiana USA.
- Indiana Alzheimer's Disease Research Center Indiana University School of Medicine Indianapolis Indiana USA.
Förderung
- NIA NIH HHS
- NLM NIH HHS
- National Institutes of Health
- Avid Radiopharmaceuticals
- Gates Ventures
- Eisai
- Novo Nordisk
- National Institute on Aging
Zitieren
APA
Mathew, S., Huang, Y. N., Bice, P., Saykin, A. J., & Risacher, S. L. (2025). Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 17(2). https://doi.org/10.1002/dad2.70132
Vancouver
Mathew S, Huang YN, Bice P, Saykin AJ, Risacher SL. Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025;17(2). doi:10.1002/dad2.70132
BibTeX
@article{Mathew2025,
author = {Mathew, Sunu and Huang, Yen-Ning and Bice, Paula and Saykin, Andrew J and Risacher, Shannon L},
title = {Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2025},
volume = {17},
number = {2},
doi = {10.1002/dad2.70132}
}
EUVIMED